RECURSION PHARMACEUTICALS, INC. ($RXRX)
Gibson Christopher โ Director
Shares
40,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 27, 2026
EPS:Est: -0.28
Transaction Details
| Insider | Gibson Christopher |
|---|---|
| Title | Director |
| Transaction Date | Feb 19, 2026 |
| Transaction Code | C Conversion |
| Acquired/Disposed | Disposed |
| Security | Class B Common Stock |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Purchased | 40,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 4,543,334 |
| Derivative | Derivative |
| Accession Number | 0001601830-26-000021 |
| Document | View SEC Filing |